NLRR-1 antagonists and uses thereof

Details for Australian Patent Application No. 2008308761 (hide)

Owner GENENTECH, INC.

Inventors Hongo, Jo-Anne S.; Hazen, Meredith; Smith, Victoria; Stinson, Susanna

Agent Griffith Hack

Pub. Number AU-A-2008308761

PCT Pub. Number WO2009/046123

Priority 60/976,892 02.10.07 US

Filing date 1 October 2008

Wipo publication date 9 April 2009

International Classifications

A61K 31/5377 (2006.01)

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

A61P 35/00 (2006.01) Antineoplastic agents

C07K 16/18 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies - against material from animals or humans

C07K 16/30 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

C12N 5/20 (2006.01) Undifferentiated human, animal or plant cells, e.g. cell lines - one of the fusion partners being a B lymphocyte

C12N 15/11 (2006.01) Mutation or genetic engineering - DNA or RNA fragments

Event Publications

15 April 2010 PCT application entered the National Phase

  PCT publication WO2009/046123 Priority application(s): WO2009/046123

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008308777-Method and apparatus for uplink control signaling

2008308759-Method and apparatus for preparing bone for a prosthetic device